Literatur
-
1
Bjarnason N H, Riis B J, Christiansen C.
The effect of fluvastatin on parameters of bone remodeling.
Osteoporosis International.
2001;
12
380-384
-
2 Cauley J A. http://www.chumd.com/Research/Pharmacy_Drug/22-SEP-2000/103 008_en.html in: Statins Stumble in Bone Studies
-
3
Cauley J A, Jackson R, Pettinger M, LaCroix A, Bauer D, Chen Z, Daugherty S, Hsia J, Lewis C E, McGowan J, McNeeley S G, Passaro M.
Statin Use and Bone Mineral Density (BMD) in Older Women: The Women’s Health Initiative Observational Study (WHI-OS).
J Bone Miner Res.
2000;
15
1068
(Suppl 1))
-
4
Chan K A, Andrade S E, Boles M, Buist D SM, Chase G A, Donahue J G, Goodman M J, Gurwitz J H, LaCroix A Z, Platt R.
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
Lancet.
2000;
355
2185-2188
-
5
Edwards C J, Hart D J, Spector T D.
Oral statins and increased bone mineral density in postmenopausal women.
Lancet.
2000;
355
2218-2219
-
6
Gutierrez G G, Garrett I R, Rossini G, Castano M, Chapa G, Escobedo A, Esparza J, Horn D, Qiao M, Taylor S, Lalka D, Mundy G R.
Dermal application of lovastatin to rats causes greater increases in bone formation and plasma concentrations than when administered by oral gavage.
J Bone Miner Res.
2000;
15
SU397
(Suppl 1))
-
7
Hennessy S, Strom B L.
Statins and fracture risk.
JAMA.
2001;
285
1888-1889
-
8
Jick H, Zornberg G L, Jick S S, Seshardri S, Drachman D A.
Statins and the risk of dementia.
Lancet.
2000;
356
1627-1631
-
9
LaCroix A Z, Cauley J A, Jackson R, McGowan J, Pettinger M, Hsia J, Chen Z, Lewis C, Bauer D C, Daugherty S, McNeeley S G, Passaro M.
Does statin use reduce the risk of fractures in postmenopausal women. Results from the Women’s Health Initiative Observational Study (WHI-OS).
J Bone Min Res.
2000;
15
S155
(Suppl 1))
-
10
Laufs U, Werner N, Böhm M, Nickenig G.
Statine als neue Therapiemöglichkeit der Osteoporose?.
Dtsch Med Wochenschr.
2001;
126
565-568
-
11
Meier C R, Schlienger R G, Kraenzlin M E, Schlegel B, Jick H.
HMG-CoA reductase inhibitors and the risk of fractures.
JAMA.
2000;
283
3205-3210
-
12
Pedersen T R.
Statins and the risk of fracture (comment).
JAMA.
2000;
284
1921
-
13
Reid I R, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, Machon S, Sharpe N.
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial.
Lancet.
2001;
357
509-512
-
14
VanStaa T P, Wegman S, DeVries F, Leufkens B, Cooper C.
Use of statins and risk of fractures.
J Bone Miner Res.
2000;
15
1067
(suppl 1))
-
15
VanStaa T P, Wegman S, DeVries F, Leufkens B, Cooper C.
Use of statins and risk of fractures.
JAMA.
2001;
285
1850-1855
-
16
Wang P S, Solomon D H, Mogun H, Avorn J.
HMG-CoA reductase inhibitors and the risk of hip fractures in the elderly patients.
JAMA.
2000;
283
3211-3216
Dr. Hans Richard Barthel
Praxis für Innere Medizin und Rheumatologie
Herzog-Adolph-Straße 4
61462 Königstein
eMail: hrbarthel@hotmail.com
